Featured Publications
Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive–compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial
Ching T, Grazioplene R, Bohner C, Kichuk S, DePalmer G, D’Amico E, Eilbott J, Jankovsky A, Burke M, Hokanson J, Martins B, Witherow C, Patel P, Amoroso L, Schaer H, Pittenger C, Kelmendi B. Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive–compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial. Frontiers In Psychiatry 2023, 14: 1178529. PMID: 37181888, PMCID: PMC10166878, DOI: 10.3389/fpsyt.2023.1178529.Peer-Reviewed Original ResearchObsessive-compulsive disorderPrimary endpointPsilocybin effectsNeural effectsRefractory obsessive-compulsive disorderNon-crossover designOpen-label doseStandard care treatmentOpen-label studyVisual analog scale ratingsTreatment of OCDEffects of psilocybinOCD symptomsInstitutional review boardYale-Brown ObsessivePrimary outcomeSingle doseCare treatmentOral psilocybinInformed consentReview boardNeurobiological mechanismsCompulsive ScalePsychological supportTrials
2023
Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals
Feng R, Ching T, Bartlett A, La Torre J, Williams M. Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals. Journal Of Psychoactive Drugs 2023, 56: 603-615. PMID: 37652035, DOI: 10.1080/02791072.2023.2253535.Peer-Reviewed Original ResearchPsychedelic-assisted psychotherapyNon-Hispanic white participantsBIPOC participantsWhite participantsEffectiveness of psychoeducationHierarchical regression modelsBIPOC individualsMental disordersPsychoeducational componentsPsychoeducationPsychotherapyParticipants' likelihoodBarriers to recruitmentSeekingTest effectsParticipantsPhysical safetyBIPOCFuture trialsIndividualsTrialsDisordersRegression modelsANCOVAClinical trials
2022
MDMA-Assisted Therapy for Posttraumatic Stress Disorder: A Mixed-Methods Case Study of a Participant of Color From an Open-Label Trial
Ching T, Williams M, Reed S, Kisicki M, Wang J, Yazar-Klosinski B, Emerson A, Doblin R. MDMA-Assisted Therapy for Posttraumatic Stress Disorder: A Mixed-Methods Case Study of a Participant of Color From an Open-Label Trial. Journal Of Humanistic Psychology 2022, 64: 692-722. DOI: 10.1177/00221678221076993.Peer-Reviewed Original ResearchPosttraumatic stress disorderOpen-label trialTreatment-resistant posttraumatic stress disorderStress disorderPTSD symptomsPrevious clinical trialsPTSD symptom reductionInterpretative phenomenological analysisMechanism of actionPromising efficacyClinical trialsSymptom recoveryTreatment approachesSymptom reductionSymptom changeParticipants of colorTrialsTherapySymptomsDisordersAdditional aimMechanisms of changeParticipantsAdditional effectCase profiles